Thought Leaders Shaping the Emerging Wireless Life Science Space to Share Vision and Insights at WLSA Convergence Summit

LA JOLLA, Calif., April 28 /PRNewswire/ -- The Wireless-Life Sciences Alliance (WLSA) today announced key industry speakers and open registration for its Wireless Health Commercialization Day on May 13, 2010.  This meeting is part of the 5th annual WLSA Convergence Summit, a three-day conference sponsored by the premier trade organization dedicated solely to creating value and improving health through wireless communications technologies. The conference is scheduled for May 11-13 at Estancia Hotel & Spa, La Jolla, California.

(Logo:  http://www.newscom.com/cgi-bin/prnh/20100428/LA95139LOGO)

Now open to general registration, the Wireless Health Commercialization Day on May 13, will feature product life cycle workshops led by the esteemed product design teams of IDEO and Insight Product Development, including:

Human-Centered Innovation: A Path to Successful Products – IDEO will lead a series of hands-on activities demonstrating techniques that ensure products and services meet user needs.

What's Your "Next" in Forming New Opportunities? – Led by Insight Product Development, this workshop addresses what happens after a product or service is launched.

In addition to these workshops, senior management representing AT&T, Ascension Health, St. Jude Medical, Gambro, DexCom, ResMed, Zeo, Midmark, Reglera, IDEO, Insight and Qualcomm, will participate in panel discussions to debate these complex topics:

Going Wireless: Is a Smart Phone App the Only Way?

Wireless Healthcare Without Borders

Sleep Disorders…Prescribe or Subscribe?

Commercialization Day will conclude with an opportunity for attendees to "Meet the Experts" and visit with featured speakers and panelists, followed by a private networking reception and product demos.  Attendees may register online here.

About the WLSA Convergence Summit.  The annual meeting is a three-day conference.  Day 1, the Investor's Meeting, showcases 12 innovative companies chosen as part of the Triple Tree I Award Program for Wireless-Life Sciences Alliance®.  In addition to company presentations, this meeting will highlight keynotes including:

• Terrance H. Gregg, President and CEO of DexCom Inc. and Special Venture Partner at Galen Partners. Gregg will discuss "Notes from the Frontlines:  Building MiniMed and now DexCom – Having More Fun While Working Even Harder to Succeed."
• Dr. Mohit Kaushal, Director of Connected Health at the Federal Communications Commission (FCC), will provide an update on the U.S. broadband plan and its implications for healthcare.

Admission to the WLSA Investors' Meeting is complimentary to qualified investors and a limited number of seats are available to others.

The WLSA Convergence Summit on Day 2 is an invitation-only program for C-level executives from WLSA members, thought leaders and policy makers, featuring brief presentations by the attendees and moderated conversations in interview and panel style.

"Each speaker at the Summit is a recognized pioneer in the emerging wireless healthcare convergence industry," said Robert B. McCray, WLSA President & CEO. "Those interested in hearing more are encouraged to contact us and consider joining WLSA as a member."

For information about the WLSA and the 5th annual WLSA Convergence Summit, visit www.wirelesslifesciences.org/wlsa-events or contact Andrea Jackson.

About WLSA

The Wireless-Life Sciences Alliance (WLSA) is a special purpose trade organization for innovators, globally relevant companies, scientists, physicians, and policy makers. The WLSA is dedicated to creating value and improving health, globally, through the convergence of communications technologies, consumers, caregivers and all sectors of the life sciences and technology environment. WLSA partners and companies all over the world are using wireless health innovations to better manage chronic conditions, preempt disease and improve the lives of the elderly and under-served populations around the world.

SOURCE Wireless-Life Sciences Alliance